DaVita Inc (STU:TRL)
€ 139.4 0.3 (0.22%) Market Cap: 11.37 Bil Enterprise Value: 21.66 Bil PE Ratio: 16.22 PB Ratio: 32.13 GF Score: 80/100

DaVita Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 07:05PM GMT
Release Date Price: €69.82 (+0.72%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

I'm Steven Valiquette, the health care services analyst here at Barclays. Yes. So the next company here is DaVita. With us from the company, we have the company's CFO, Joel Ackerman; and also Nic Eliason, VP is in the audience as well.

This will be a fireside chat. So I think with that, we'll just -- we'll dive right in.

Joel Ackerman
DaVita Inc. - CFO & Treasurer

Great.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Sure. So first question here, it seems like for all the provider companies, the topic of labor is still at the forefront of investors' minds. So I guess we'll just dive right into that before we start talking about some of the other parts of the business and some of the growth drivers. But I think labor expense, you guys have talked about that getting better. You quantified some amounts on the temp staffing portion, but also just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot